HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-JUL-13 4LI7 TITLE TANKYRASE-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR 4-CHLORO-5-CYANO- TITLE 2 N-{2-[4-(4-FLUOROBENZOYL)PIPERIDIN-1-YL]ETHYL}-2-METHOXYBENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 1105-1325; COMPND 5 SYNONYM: TANK1, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 5, COMPND 6 ARTD5, POLY [ADP-RIBOSE] POLYMERASE 5A, TNKS-1, TRF1-INTERACTING COMPND 7 ANKYRIN-RELATED ADP-RIBOSE POLYMERASE, TANKYRASE I; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.KIRBY,T.STAMS REVDAT 3 28-FEB-24 4LI7 1 REMARK SEQADV REVDAT 2 02-OCT-13 4LI7 1 JRNL REVDAT 1 14-AUG-13 4LI7 0 JRNL AUTH M.D.SHULTZ,A.K.CHEUNG,C.A.KIRBY,B.FIRESTONE,J.FAN,C.H.CHEN, JRNL AUTH 2 Z.CHEN,D.N.CHIN,L.DIPIETRO,A.FAZAL,Y.FENG,P.D.FORTIN, JRNL AUTH 3 T.GOULD,B.LAGU,H.LEI,F.LENOIR,D.MAJUMDAR,E.OCHALA, JRNL AUTH 4 M.G.PALERMO,L.PHAM,M.PU,T.SMITH,T.STAMS,R.C.TOMLINSON, JRNL AUTH 5 B.B.TOURE,M.VISSER,R.M.WANG,N.J.WATERS,W.SHAO JRNL TITL IDENTIFICATION OF NVP-TNKS656: THE USE OF JRNL TITL 2 STRUCTURE-EFFICIENCY RELATIONSHIPS TO GENERATE A HIGHLY JRNL TITL 3 POTENT, SELECTIVE, AND ORALLY ACTIVE TANKYRASE INHIBITOR. JRNL REF J.MED.CHEM. V. 56 6495 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23844574 JRNL DOI 10.1021/JM400807N REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.5 REMARK 3 NUMBER OF REFLECTIONS : 22084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1071 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 120 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3294 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.83000 REMARK 3 B22 (A**2) : 14.79000 REMARK 3 B33 (A**2) : -9.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.97000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4LI7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000080661. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22921 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.16000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.120 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER METHODS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 3350, 100MM BIS-TRIS, PH 6.2, REMARK 280 100 MM AMMONIUM SULFATE, 9 MG/ML TNKS1, 1 MM INHIBITOR, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.20000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.20000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1104 REMARK 465 TYR A 1203 REMARK 465 ILE A 1204 REMARK 465 GLY A 1205 REMARK 465 PRO A 1282 REMARK 465 SER A 1283 REMARK 465 VAL A 1284 REMARK 465 ASN A 1285 REMARK 465 GLY A 1286 REMARK 465 LEU A 1287 REMARK 465 ALA A 1288 REMARK 465 PRO A 1316 REMARK 465 SER A 1317 REMARK 465 GLN A 1318 REMARK 465 THR A 1319 REMARK 465 ALA A 1320 REMARK 465 THR A 1321 REMARK 465 ALA A 1322 REMARK 465 ALA A 1323 REMARK 465 GLU A 1324 REMARK 465 GLN A 1325 REMARK 465 LYS A 1326 REMARK 465 THR A 1327 REMARK 465 GLY B 1104 REMARK 465 TYR B 1203 REMARK 465 ILE B 1204 REMARK 465 GLY B 1205 REMARK 465 ALA B 1315 REMARK 465 PRO B 1316 REMARK 465 SER B 1317 REMARK 465 GLN B 1318 REMARK 465 THR B 1319 REMARK 465 ALA B 1320 REMARK 465 THR B 1321 REMARK 465 ALA B 1322 REMARK 465 ALA B 1323 REMARK 465 GLU B 1324 REMARK 465 GLN B 1325 REMARK 465 LYS B 1326 REMARK 465 THR B 1327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B1134 6.32 -69.69 REMARK 500 ARG B1149 137.42 -172.20 REMARK 500 ASN B1173 49.71 -148.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1XP A 1405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1XP B 1404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4LI6 RELATED DB: PDB REMARK 900 RELATED ID: 4LI8 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE CONFLICT M1266I PRESENT IN UNP ENTRY O95271 DBREF 4LI7 A 1105 1327 UNP O95271 TNKS1_HUMAN 1105 1327 DBREF 4LI7 B 1105 1327 UNP O95271 TNKS1_HUMAN 1105 1327 SEQADV 4LI7 GLY A 1104 UNP O95271 EXPRESSION TAG SEQADV 4LI7 ILE A 1266 UNP O95271 MET 1266 SEE REMARK 999 SEQADV 4LI7 GLY B 1104 UNP O95271 EXPRESSION TAG SEQADV 4LI7 ILE B 1266 UNP O95271 MET 1266 SEE REMARK 999 SEQRES 1 A 224 GLY GLY THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS SEQRES 2 A 224 GLU TYR GLN SER VAL GLU GLU GLU MET GLN SER THR ILE SEQRES 3 A 224 ARG GLU HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE SEQRES 4 A 224 ASN ARG TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN SEQRES 5 A 224 LYS LYS LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU SEQRES 6 A 224 VAL SER GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET SEQRES 7 A 224 LEU PHE HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS SEQRES 8 A 224 LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET SEQRES 9 A 224 PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SEQRES 10 A 224 SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY SEQRES 11 A 224 CYS PRO THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS SEQRES 12 A 224 ARG GLN MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER SEQRES 13 A 224 PHE LEU GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO SEQRES 14 A 224 PRO GLY HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN SEQRES 15 A 224 GLY LEU ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU SEQRES 16 A 224 GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET SEQRES 17 A 224 LYS PRO GLU ALA PRO SER GLN THR ALA THR ALA ALA GLU SEQRES 18 A 224 GLN LYS THR SEQRES 1 B 224 GLY GLY THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS SEQRES 2 B 224 GLU TYR GLN SER VAL GLU GLU GLU MET GLN SER THR ILE SEQRES 3 B 224 ARG GLU HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE SEQRES 4 B 224 ASN ARG TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN SEQRES 5 B 224 LYS LYS LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU SEQRES 6 B 224 VAL SER GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET SEQRES 7 B 224 LEU PHE HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS SEQRES 8 B 224 LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET SEQRES 9 B 224 PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SEQRES 10 B 224 SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY SEQRES 11 B 224 CYS PRO THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS SEQRES 12 B 224 ARG GLN MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER SEQRES 13 B 224 PHE LEU GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO SEQRES 14 B 224 PRO GLY HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN SEQRES 15 B 224 GLY LEU ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU SEQRES 16 B 224 GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET SEQRES 17 B 224 LYS PRO GLU ALA PRO SER GLN THR ALA THR ALA ALA GLU SEQRES 18 B 224 GLN LYS THR HET SO4 A1401 5 HET SO4 A1402 5 HET SO4 A1403 5 HET NA A1404 1 HET 1XP A1405 31 HET SO4 B1401 5 HET SO4 B1402 5 HET NA B1403 1 HET 1XP B1404 31 HETNAM SO4 SULFATE ION HETNAM NA SODIUM ION HETNAM 1XP 4-CHLORO-5-CYANO-N-{2-[4-(4-FLUOROBENZOYL)PIPERIDIN-1- HETNAM 2 1XP YL]ETHYL}-2-METHOXYBENZAMIDE FORMUL 3 SO4 5(O4 S 2-) FORMUL 6 NA 2(NA 1+) FORMUL 7 1XP 2(C23 H23 CL F N3 O3) FORMUL 12 HOH *182(H2 O) HELIX 1 1 ASP A 1115 THR A 1128 1 14 HELIX 2 2 ASN A 1155 GLU A 1171 1 17 HELIX 3 3 PHE A 1188 GLY A 1196 1 9 HELIX 4 4 ASP A 1198 ALA A 1202 5 5 HELIX 5 5 ASN A 1217 GLN A 1223 1 7 HELIX 6 6 GLY A 1227 GLY A 1231 5 5 HELIX 7 7 ARG A 1296 GLU A 1298 5 3 HELIX 8 8 ASP B 1115 THR B 1128 1 14 HELIX 9 9 ASN B 1155 GLU B 1172 1 18 HELIX 10 10 PHE B 1188 GLY B 1196 1 9 HELIX 11 11 ASP B 1198 ALA B 1202 5 5 HELIX 12 12 ASN B 1217 GLN B 1223 1 7 HELIX 13 13 GLY B 1227 GLY B 1231 5 5 HELIX 14 14 ARG B 1296 GLU B 1298 5 3 SHEET 1 A 5 ILE A1107 ASP A1110 0 SHEET 2 A 5 TYR A1145 VAL A1154 -1 O LYS A1152 N LEU A1109 SHEET 3 A 5 ALA A1300 ILE A1310 -1 O LEU A1305 N GLN A1151 SHEET 4 A 5 ARG A1247 THR A1255 -1 N ARG A1247 O TYR A1308 SHEET 5 A 5 GLU A1179 HIS A1184 -1 N LEU A1182 O CYS A1252 SHEET 1 B 4 ILE A1212 PHE A1214 0 SHEET 2 B 4 GLU A1291 ILE A1294 -1 O ILE A1294 N ILE A1212 SHEET 3 B 4 SER A1277 GLY A1280 -1 N VAL A1278 O VAL A1293 SHEET 4 B 4 SER A1259 GLN A1262 1 N PHE A1260 O ILE A1279 SHEET 1 C 5 ILE B1107 ASP B1110 0 SHEET 2 C 5 ARG B1144 VAL B1154 -1 O LYS B1152 N LEU B1109 SHEET 3 C 5 ALA B1300 MET B1311 -1 O LEU B1305 N GLN B1151 SHEET 4 C 5 ARG B1247 THR B1255 -1 N ARG B1247 O TYR B1308 SHEET 5 C 5 GLU B1179 HIS B1184 -1 N LEU B1182 O CYS B1252 SHEET 1 D 4 ILE B1212 PHE B1214 0 SHEET 2 D 4 GLU B1291 ILE B1294 -1 O ILE B1294 N ILE B1212 SHEET 3 D 4 SER B1277 GLY B1280 -1 N VAL B1278 O VAL B1293 SHEET 4 D 4 SER B1259 GLN B1262 1 N PHE B1260 O ILE B1279 LINK NA NA A1404 O HOH A1531 1555 1555 3.19 SITE 1 AC1 7 ARG A1130 HIS A1132 ARG A1133 LYS A1220 SITE 2 AC1 7 GLN A1223 TYR A1289 HOH A1508 SITE 1 AC2 4 HIS A1176 HIS A1177 ASN A1178 HIS B1176 SITE 1 AC3 4 ASN A1143 PRO A1313 GLU A1314 HOH A1579 SITE 1 AC4 3 HIS A1184 TYR A1213 1XP A1405 SITE 1 AC5 20 PHE A1183 HIS A1184 GLY A1185 SER A1186 SITE 2 AC5 20 PHE A1188 ALA A1191 LYS A1195 GLY A1196 SITE 3 AC5 20 PHE A1197 ASP A1198 HIS A1201 TYR A1213 SITE 4 AC5 20 SER A1221 TYR A1224 ILE A1228 GLU A1291 SITE 5 AC5 20 NA A1404 HOH A1510 HOH A1531 HOH A1564 SITE 1 AC6 7 ARG B1130 HIS B1132 ARG B1133 LYS B1220 SITE 2 AC6 7 GLN B1223 HOH B1519 HOH B1538 SITE 1 AC7 5 HIS A1176 HIS B1176 HIS B1177 ASN B1178 SITE 2 AC7 5 GLU B1179 SITE 1 AC8 3 HIS B1184 TYR B1213 1XP B1404 SITE 1 AC9 19 PHE B1183 HIS B1184 GLY B1185 SER B1186 SITE 2 AC9 19 PHE B1188 ALA B1191 ILE B1192 GLY B1196 SITE 3 AC9 19 PHE B1197 ASP B1198 HIS B1201 ALA B1202 SITE 4 AC9 19 TYR B1213 SER B1221 TYR B1224 ILE B1228 SITE 5 AC9 19 GLU B1291 NA B1403 HOH B1505 CRYST1 124.400 44.000 87.400 90.00 90.40 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008039 0.000000 0.000056 0.00000 SCALE2 0.000000 0.022727 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011442 0.00000